| HOME >> BIOLOGY >> TECHNOLOGY |
YONGYE BIOTECHNOLOGY INTERNATIONAL, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
Yongye
Biotechnology The predecessor
International, Inc. Inner
and Subsidiaries Mongolia Yongye
For Six Months For Six Months
Ended June Ended June
30, 2008 30, 2007
(Unaudited) (Unaudited)
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income $7,742,185 $3,358,428
Adjustments to Reconcile Net
Income to Net Cash Used in Operating
Activities
Depreciation and Amortization 93,263 10,644
Loss on Disposal of Fixed Assets -- 146,714
Provision for Minority Interest 1,035,005 --
Changes in Assets and Liabilities:
Accounts Receivable, net (20,613,347) (6,557,611)
Inventories (5,196,266) (319,604)
Other Receivables, net (216,795) (1,063,081)
Advances to Suppliers (65,453) 352,866
Prepaid Expense -- (7,271)
Accounts Payable and Accrued
Expenses 6,772,337 288,578
Tax Payable 406,530 49,894
Due to Related Parties 2,397,465 838,369
Other Payables 40,424 (1,759,915)
'/>"/>
| SOURCE Yongye Biotechnology International, Inc. Copyright©2008 PR Newswire. All rights reserved |